StemBioSys CEO and leadership

President & CEO of StemBioSys as well as member of the board of directors. This San Antonio, TX based start up has a unique proprietary technology that currently supports expansion of a variety of cell types. The company is also exploring other therapeutic applications of its patented HPME technology. The company's second product - cord blood derived Mesenchymal stem cells - will be available to the research market in the summer of 2016.

Over 25 years of experience in a broad range of industries and management topics. Significant management consulting experience at the partner level in Life Sciences that I have applied in both traditional private sector environments (Pharmaceutical, Medical Device Companies) as well as in a variety of U.S. Federal Government and International NGO organizations. Experience in the Luxury Goods sector. Extensive international experience in Western Europe and Asia.

Member of the Ross School of Business Advisory Board at the University of Michigan in Ann Arbor.

Eileen Meier is a Chief Sales Officer at StemBioSys Inc and is based in San Antonio, Texas. She has worked as Senior Director, Regional Sales at Indivumed Inc; Account Executive at Covance Laboratories; and Regional Sales Director at Aptuit. Eileen attended University of Wisconsin-Madison.

Mark Horsey is a Chief Financial Officer, Secretary & Treasurer at StemBioSys Inc; CFO at Rapamycin Holdings Inc; and Chief Financial Officer at Rapamycin Holdings, Inc. dba Emtora Biosciences and is based in San Antonio, Texas. He has worked as Controller - US Consumer Business Unit at Dell, District Manager - Installed Services at Sears, and Director of Finance - Multiple Sclerosis/San Antonio Operations at Genzyme. Mark attended St. Edward's University between 1996 and 1998 and The University of Texas at Austin between 1992 and 1996.